IFP Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

IFP Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-476	Closed	-$26K	–	4235
2018 Q1	$26K	Hold	476	–	–	﹤0.01%	2235
2017 Q4	$26K	Sell	476 -136	-22%	-$7.44K	﹤0.01%	2264
2017 Q3	$35K	Sell	612 -7	-1%	-$410	﹤0.01%	2231
2017 Q2	$37K	Sell	619 -151	-20%	-$8.6K	﹤0.01%	2178
2017 Q1	$42K	Buy	+770	New	+$37.9K	﹤0.01%	2037

IFP Advisors's BIVV Position: Q2 2018 in Review

IFP Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q2 2018, closing a stake of 476 shares — an estimated $26K sold.

IFP Advisors first reported a position in BIVV in Q1 2017 and held it in 5 quarters. The position peaked at $42K in Q1 2017. 0 funds tracked by Wall St. Rank hold BIVV as of Q2 2018.

IFP Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
IFP Advisors sold 476 Bioverativ Inc. Common Stock shares in Q2 2018, an estimated $26K.
IFP Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 5 quarters.
IFP Advisors's Bioverativ Inc. Common Stock position peaked at $42K in Q1 2017.
0 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.